false
Catalog
12 Common Myths and Misconceptions about MOUD
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Buprenorphine is a highly effective treatment for opioid use disorder, dispelling myths about its use replacing one addiction with another. It is regarded as the gold standard, providing protection against respiratory depression from fentanyl. The video discusses the distinction between physical dependence and addiction, emphasizing the medication's benefits even without intensive therapy. Understanding misconceptions and utilizing holistic support systems are crucial for successful outcomes. Key topics covered include guidelines on dosing, stability, pregnancy considerations, surgery, family support, and community engagement. Additionally, the transcript delves into recent regulatory changes, dosing protocols, formulations, patient education, safety measures, and monitoring for optimal outcomes. Practical advice is provided on overcoming challenges, initiating treatment, adjusting doses, managing chronic pain, and transitioning from opioid therapy. Removing barriers to buprenorphine prescribing is highlighted as essential for effective treatment of opioid use disorder.
Keywords
Buprenorphine
opioid use disorder
addiction
respiratory depression
fentanyl
physical dependence
holistic support
dosing guidelines
pregnancy considerations
surgery
family support
community engagement
regulatory changes
patient education
chronic pain management
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English